The role of PKN, a fatty acid-and Rho small GTPase-activated protein kinase, in cell-cycle regulation was analyzed. Microinjection of the active form of PKN into a Xenopus embryo caused cleavage arrest, whereas normal cell division proceeded in the control embryo microinjected with buffer or the inactive form of PKN. Exogenous addition of the active form of PKN delayed mitotic timing in Xenopus egg cycling extracts judging by morphology of sperm nuclei and Cdc2͞cyclin B histone H1 kinase activity. The kinase-negative form of PKN did not affect the timing, suggesting that delayed mitotic timing depends on the kinase activity of PKN. The dephosphorylation of Tyr-15 of Cdc2 was also delayed in correlation with Cdc2͞cyclin B histone H1 kinase activation in extracts containing active PKN. The Cdc25C activity for the dephosphorylation of Tyr-15 in Cdc2 was suppressed by pretreatment with the active form of PKN. Furthermore, PKN efficiently phosphorylated Cdc25C in vitro, indicating that PKN directly inhibits Cdc25C activity by phosphorylation. These results suggest that PKN plays a significant role in the control of mitotic timing by inhibition of Cdc25C.
P rotein phosphorylation͞dephosphorylation reaction is a key event in the regulation of cell division. In dividing eukaryotic cells, entry into mitosis is governed by the M phase-promoting factor. This factor consists of the Cdc2 protein kinase and cyclin B and acts by phosphorylating substrates that are essential for the execution of mitotic processes (1) . Before mitosis, the activity of Cdc2͞cyclin B histone H1 kinase is suppressed through inhibitory phosphorylation of Tyr-15 and Thr-14 residues of Cdc2 by the Wee1 and Myt1 kinases (2) (3) (4) (5) . At onset of mitosis, the phosphatase Cdc25C removes these inhibitory phosphate groups from Cdc2 and thereby activates Cdc2͞cyclin B histone H1 kinase. The activity of Cdc25C is strictly regulated, probably by phosphorylation, and is low during interphase and high at mitosis (6, 7) . Thus, entry into mitosis is under the control of a tightly regulated network of protein kinases and phosphatases. Although upstream players such as Chk1 and Cds1 (8) (9) (10) in the tyrosine phosphorylation͞dephosphorylation of Cdc2 have been identified, it remains unclear how these enzymes are controlled during the cell cycle. There is a possibility that the unidentified protein kinase or kinases might participate in upstream regulation.
PKN is a serine͞threonine protein kinase that has a catalytic domain highly homologous to protein kinase C (PKC) in the carboxyl-terminal region and a unique regulatory domain in the amino-terminal region (11) (12) (13) . The amino-terminal region of PKN contains three repeats of a leucine zipper-like motif, and its kinase activity is stimulated by fatty acids such as arachidonic acid (13) . We reported that PKN translocates from the cytosol to the nucleus of fibroblasts on exposure to stress such as heat shock and serum starvation (14) and that PKN is cleaved during apoptosis, presumably by caspase-3, which generates a constitutively active kinase fragment (15) . Furthermore, we found that PKN is one of the downstream targets of small GTPase, Rho (16 -18) . Rho regulates actinbased cytoskeletal structures, including focal adhesions, stress fibers, and the contractile ring, and works as a switch in stimulus-evoked cell adhesion and cytokinesis (19, 20) . Expression of the dominant-negative form of Rho kinase, another protein kinase regulated by Rho, inhibits the cytokinesis of the Xenopus embryo and mammalian cells (21) . The overexpression of citron (another downstream target of Rho) mutant results in the production of multinucleate cells, and its kinaseactive mutant causes abnormal contraction during cytokinesis (22) . These findings suggest that PKN also may participate in cell-cycle control.
The present study analyzed the role of PKN in the regulation of the cell cycle. We found that exogenous addition of the active form of PKN delays the mitosis of Xenopus egg cycling extracts.
In vitro experiments indicated that PKN phosphorylates and inhibits Cdc25C, revealing that delayed mitotic timing in the egg extracts is caused by inhibition of Cdc25C.
Materials and Methods
Antibodies. Antiphospho-Tyr-15 of Cdc2 polyclonal antibody and anti-Cdc2 monoclonal antibody were obtained from New England Biolabs and Santa Cruz Biotechnology, respectively.
Recombinant Baculoviruses and Protein Production.
Recombinant viruses encoding glutathione S-transferase (GST)͞PKN (543-942) (the constitutively active form of human PKN) and GST͞PKN (543-942)-K644E (the kinase-negative form of PKN) have been described (23) . The recombinant viruses for GST͞Wee1 (full-length Xenopus Wee1), GST͞cyclin B1 (the indestructible form of Xenopus cyclin B1), and histidine (His) 6 ͞Cdc2 (N133A) (the kinase-negative form of Xenopus Cdc2) were provided by M. Iwabuchi (Tokyo Institute of Technology, Yokohama, Japan). Recombinant virus encoding GST͞PKC (386 -737) (the constitutively active form of rat PKC) was generated by using the baculovirus transfer vector of pBlueBacHis͞GST (23) and the cDNA fragment encoding the catalytic domain of rat PKC (24) . Recombinant virus encoding GST͞Cdc25C was generated by using the baculovirus transfer vector of pBlueBacHis͞GST and the full-length Xenopus Cdc25C cDNA (25) provided by N. Nakajo (Kyushu University, Fukuoka, Japan). All GST-fused proteins were expressed in Sf9 cells and purified by glutathione Sepharose 4B Abbreviations: GST, glutathione S-transferase; His, histidine; PKC, protein kinase C.
(Amersham Pharmacia) chromatography as described (23). Cdc2 (N133A)͞cyclin B complex was purified by using glutathione Sepharose 4B from Sf9 cells that had been simultaneously infected with recombinant baculoviruses encoding (His) 6 ͞Cdc2 (N133A) and GST͞cyclin B. Fig. 1 shows the protein preparations used in this study.
Microinjection into Xenopus Embryo. Proteins were concentrated, and solvents were replaced by microinjection buffer (20 mM Tris⅐HCl, pH 7.5͞88 mM NaCl) with Centricon-10 (Amicon). Sexually mature females of Xenopus laevis were induced to ovulate by injection of human chorionic gonadotropin (500 units per female). Eggs were artificially inseminated, and embryos were cultured in 20% MMR (1 mM Hepes-KOH, pH 7.8͞20 mM NaCl͞0.4 mM KCl͞0.2 mM MgCl 2 ͞0.4 mM CaCl 2 ͞0.02 mM EDTA) containing 5% Ficoll (Amersham Pharmacia). Embryos were selected for injection at the beginning of the first cleavage furrow formation, and 10 nl of protein sample was injected into one blastomere. Cleavage arrest of the injected blastomere was observed 5 h after fertilization.
Cycling Xenopus Egg Extracts. Xenopus egg extracts that reproduce the progression of embryonic mitotic cycles were prepared according to a modification of the procedure described by Murray (26) . Briefly, eggs were dejellied with 2.5% thioglycolic acid (pH 8.2) and activated by treatment with 0.2 g͞ml of calcium ionophore A23187 for 3 min. Activated eggs were incubated in 20% MMR for 25 min, then washed with extraction buffer (20 mM Hepes-KOH, pH 7.4͞100 mM KCl͞5 mM MgCl 2 ͞0.1 mM CaCl 2 ) containing 50 g͞ml of cytochalasin B. After being transferred to a test tube, eggs were chilled on ice for 5 min, and cytoplasmic extract was obtained by centrifugation at 15,000 ϫ g for 10 min. The extracts were recentrifuged to remove contaminating lipid and mixed with 1:50 vol͞vol of ATP solution (500 mM phosphocreatine͞50 mM MgCl 2 ͞50 mM ATP) for final cycling extracts. To monitor the cell-cycle phase of egg extracts, sperm that had been demembranated with 0.05% lysolecithin were added to the extracts at the start of incubation, and the morphology of sperm chromatin was visualized by fluorescence with the DNA-binding dye Hoechst 33342. The purified protein was added to the extracts (1 ng protein per 1 l extracts) at the same time as sperm chromatin.
Assay of Histone H1 Kinase. For histone H1 kinase assay (27) , extracts were quickly frozen in liquid nitrogen and stored at Ϫ80°C. Frozen extracts were thawed by adding 9 volumes of an ice-cold dilution buffer (20 mM Hepes-KOH, pH 7.5͞80 mM ␤-glycerophosphate͞20 mM EGTA͞5 mM MgCl 2 ). A total of 10 l of diluted extract was mixed with 20 l of reaction buffer (80 mM ␤-glycerophosphate͞20 mM MgCl 2 ͞0.6 mM ATP͞30 g/ml leupeptin͞30 g/ml aprotinin͞0.6 mg/ml histone H1͞37 kBq [␥-32 P] ATP) and incubated for 30 min at 25°C. Reactions were stopped by addition of SDS sample buffer and boiled for 2 min. Histone H1 was separated by SDS͞PAGE and stained with Coomassie blue, and the band was excised. The amount of 32 P incorporation into the gel slice was quantified by Cerenkov counting. 
Results and Discussion

Microinjection of the Active Form of PKN Inhibits Cell Division of
Xenopus Embryos. To analyze the effect of PKN on cell division, we microinjected the active form of PKN into one blastomere of Xenopus embryos at the two-cell stage. The active form of PKN was affinity purified from Sf9 cells as a GST-fusion protein containing the catalytic domain of PKN (Fig. 1 ). This protein is constitutively active as reported (23) . Fig. 2A shows that microinjection of the active form of PKN clearly caused cleavage arrest, whereas normal cell division proceeded in the control embryos microinjected with buffer or the inactive form of PKN. Fig. 2B shows that the arrest depended on the amounts of the active PKN. Nuclear staining of the embryos revealed normal daughter nuclei in the uninjected area but one nucleus in the cleavage-arrested area (data not shown). These results suggest that PKN affects cell-cycle progression at the mitotic phase rather than at cytokinesis. 
Exogenous Addition of the Active Form of PKN Delays Mitosis in Egg
Extracts. Xenopus egg cycling extracts have been widely used to investigate the regulation of the cell cycle and faithfully mimic many aspects of the cell cycle in vivo, including nuclear envelope breakdown and reformation (26) . Thus, to assess the role of PKN in mitotic timing, we added the active form of PKN exogenously to cycling Xenopus egg extracts. Nuclear envelope breakdown and chromatin condensation were observed in the control egg extracts 30 min after the addition of sperm nuclei, and the chromatin condensation that followed was at 75 min ( Fig. 3A) . In contrast, Fig. 3B shows that the active form of PKN elicited a substantial delay of mitosis 75-90 min after the addition of sperm nuclei. The kinase-negative form of PKN and the kinase-active form of PKC, which has a catalytic domain related to PKN, did not affect the timing of nuclear envelope breakdown (data not shown), suggesting that this process depends on the kinase activity of PKN. Early stages of the Xenopus cell cycle are controlled by activation and inactivation of the Cdc2͞cyclin B complex, the activity of which is measured as histone H1 phosphorylation. Fig. 4A shows the oscillation of histone H1 kinase activity in the Xenopus eggcycling extracts. The histone H1 kinase activity oscillated in the control extracts in correlation with the cell cycling shown in Fig. 3A . Addition of the kinase-active form of PKC to the egg-cycling extracts did not change the oscillation of Cdc2͞ cyclin B histone H1 kinase activity (Fig. 4C) . However, when the active form of PKN was added to the cycling extracts, histone H1 kinase activation was delayed (Fig. 4B) . These results suggest that the delay of mitotic timing in the egg extracts containing the active form of PKN is caused by the suppression of Cdc2 activity. Thus, we analyzed the phosphorylation of Tyr-15 of Cdc2 by immunoblot with the antibody specific for the phospho-Tyr-15 peptide of Cdc2. Cdc2 is retained in an inactive state by Thr-14 and Tyr-15 phosphorylation, and the dephosphorylation of Thr-14 and Tyr-15 by Cdc25C leads to the activation of the Cdc2͞cyclin B complex. Fig. 4 A Lower shows that the oscillation of dephosphorylation of Tyr-15 of Cdc2 correlated with Cdc2͞cyclin B histone H1 kinase activity in the control extracts. The dephosphorylation of Tyr-15 was delayed in extracts containing active PKN (Fig.  4B Lower) . These observations indicate that the suppression of Cdc2 activity is derived from the prolonged inhibitory phosphorylation of Tyr-15 of Cdc2. First, we examined whether PKN can phosphorylate Cdc2 in vitro by using the full-length GST fusion protein expressed in Escherichia coli. PKN phosphorylated Cdc2 protein but not Tyr-15 (data not shown). Furthermore, PKN did not change the activity of Cdc2 in vitro (data not shown). These results suggest that PKN does not regulate directly Cdc2͞cyclin B histone H1 kinase activity.
We then analyzed the effect of PKN on Wee1 activity in vitro by using the Cdc2͞cyclin B complex affinity purified from Sf9 cells as substrates for Wee1. Fig. 5 (lanes 1 and 2) shows that GST-fused Wee1 affinity purified from Sf9 cells substantially phosphorylated Tyr-15 of Cdc2 in the complex. Incubating Wee1 with the active form of PKN did not enhance the phosphorylation level of Tyr-15 of Cdc2 in the complex (Fig. 5, lanes 3 and  4) , indicating that PKN does not directly activate Wee1. We therefore investigated whether PKN inhibits the dephosphorylation of Tyr-15 of Cdc2 by Cdc25C. We prepared GST͞ Cdc25C from Sf9 cells and assayed the activity for dephosphorylation of Tyr-15 of Cdc2. The complex of the kinase-negative form of Cdc2 and cyclin B constituted the phosphorylated substrate because active Cdc2 can itself phosphorylate and activate Cdc25C (28) . Fig. 6 (lanes 1 and 2) shows that GST͞ Cdc25C clearly dephosphorylated Tyr-15 of Cdc2. Tyr-15 dephosphorylation was suppressed after Cdc25C was incubated with the active (Fig. 6, lanes 3 and 4) but not the inactive (Fig.  6 , lanes 5 and 6) form of PKN.
We examined whether PKN can phosphorylate Cdc25C in vitro. Fig. 7 shows that PKN efficiently phosphorylated Cdc25C in vitro. These results indicate that PKN directly inhibits Cdc25C activity by phosphorylation. PKC also phosphorylated Cdc25C. However, compared with myelin basic protein, the efficiency of PKC is lower than that of PKN. Because PKC does not delay mitotic timing, as indicated in Fig. 4 , PKN and PKC may recognize the distinct sites of Cdc25C.
The present study analyzed the biochemical properties of PKN and its role in the regulation of the cell cycle and found that PKN directly phosphorylates and inhibits mitotic regulatory phosphatase of Cdc25C. These results suggest that PKN plays a significant role in the control of mitotic timing by inhibition of Cdc25C. Although the catalytic domain of PKN is highly ho- mologous with the PKC family, and the substrate specificity of PKN is similar to that of the PKC family (13), PKC did not delay mitosis in the cycling extracts, and it phosphorylated Cdc25C less efficiently than PKN. These results suggest that PKN has a specific function for the control of mitotic timing among the PKC-related super family.
PKN has been identified as one of the downstream targets of Rho. Rho has been considered to participate in cytokinesis. It is reported that inhibition of Rho function by botulinum ADPribosyltransferase C3 or the dominant-negative form of Rhokinase blocked cytokinesis in Xenopus embryos and in sand dollars (29, 30) . However, our present results suggest that PKN activation delays mitotic timing. Although whether PKN participates in cytokinesis remains unclear, PKN may have a different function in cell-cycle regulation from other downstream targets of Rho.
We reported that PKN translocates to the nucleus on exposure to stress such as heat shock and that the constitutively active form of PKN is generated by apoptotic signaling (14, 15) . Such changes of PKN in vivo might affect cell-cycle regulation. Taken together, we speculate that PKN functions as a cellcycle regulator.
Further analysis with a mammalian system may provide important insights into cell-cycle control of PKN.
